Impact of a Magnetic Resonance Imaging (MRI) Scanner Exclusively Dedicated to Emergency in the Clinical Management of Patients Presenting With Diplopia or Dizziness (IRM-DU)

July 13, 2023 updated by: University Hospital, Strasbourg, France

IRM-DU is a prospective observational single center study conducted in an emergency department to evaluate the impact of a MRI scanner exclusively dedicated to emergency in the clinical management of patients presenting with dizziness or diplopia.

The study will compare 2 strategies : after and before availability of a MRI scanner dedicated to emergency.

The primary endpoint is the proportion of patients with a diagnosis of stroke confirmed by imaging (MRI or Computed tomography (CT)) in the group "before implementation of the emergency MRI scanner" and the group "after implementation of the emergency MRI scanner".

The hypothesis is that the availability of a MRI scanner dedicated to emergency will improve the diagnosis of stroke in patients presenting with dizziness or diplopia, and will reduce Emergency Department stay, hospital stay and hospitalisation costs.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

119

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Strasbourg, France, 67091
        • Les Hôpitaux Universitaires de Strasbourg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Primary care

All patients presented in ED with dizziness or diplopia are eligible to the study protocol

Description

Inclusion Criteria:

  • age over 18 years
  • non opponent to participate
  • dizziness or diplopia requiring brain imaging in order to eliminate stroke

Exclusion Criteria:

  • opponent to participate
  • pregnant women
  • recent cerebral trauma
  • potentially eligible to thrombolysis
  • impaired consciousness
  • unable to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Before dedicated MRI
After dedicated MRI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnosis is established on the positive signs of stroke highlighted on the CT scan or brain MRI according to the examination performed
Time Frame: 18 months
Proportion of patients with a diagnosis of stroke confirmed by cerebral radiology (MRI or scan according to examination) in the pre- and post-MRI groups.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the time of care
Time Frame: 18 months
Evaluate the time of care: time of realization of the examination of radiology (scanner or brain MRI), delay of passage in emergencies
18 months
Number of CT and brain MRI requested by the emergency physician in the before / after groups
Time Frame: 18 months
Number of CT and brain MRI requested by the emergency physician in the before / after groups
18 months
Evaluate the usual management of vertigo and diplopia
Time Frame: 18 months
Evaluate the usual management of vertigo and diplopia: number of CT and brain MRI requested by the emergency physician in the "before / after" groups; number of cerebral CT and MRI performed by the radiologist in the "before / after" groups
18 months
Evaluate the rate of new consultations in emergencies
Time Frame: 18 months
Evaluate the rate of new consultations in emergencies for a neurological reason in the month following the initial care in emergencies, and the rate of new hospitalizations for the same reason
18 months
Rate of new emergency department visits for neurological
Time Frame: the month following initial emergency care
Rate of new emergency department visits for neurological reasons in the month following initial emergency care
the month following initial emergency care
Evaluate the irradiation rate
Time Frame: 18 months
Evaluate the irradiation rate related to the initial radiological examination performed during emergency care
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sabrina GARNIER KEPKA, Les Hôpitaux Universitaires de Strasbourg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2018

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

January 24, 2020

Study Registration Dates

First Submitted

July 23, 2018

First Submitted That Met QC Criteria

September 4, 2018

First Posted (Actual)

September 7, 2018

Study Record Updates

Last Update Posted (Actual)

July 14, 2023

Last Update Submitted That Met QC Criteria

July 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on MRI

3
Subscribe